Ascendis Pharma AS (ASND : NASDAQ)
Common Stock
$238.90
USD
+4.57 (1.95%)
Last updated: 2026-10-21
Follow ASND
ASND
Ascendis Pharma AS
WealthAwesomePerformance
1 Day
+1.95%
1 Week
+5.24%
1 Month
+0.55%
YTD
+3.35%
Key Statistics
Market Cap
$15.42B
52W High
$282.15
52W Low
$188.07
P/E Ratio
17.63
50 Day MA
$243.21
200 Day MA
$236.69
Beta
0.48
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/21/2026 | $236.00 | $240.21 | $235.50 | $238.90 | $238.90 | 662,038 |
| 10/20/2026 | $230.19 | $235.88 | $229.88 | $234.33 | $234.33 | 394,722 |
| 10/19/2026 | $227.44 | $233.19 | $225.81 | $229.95 | $229.95 | 1,268,039 |
| 10/16/2026 | $226.62 | $226.76 | $223.78 | $225.25 | $225.25 | 680,300 |
| 10/15/2026 | $230.40 | $234.01 | $226.06 | $226.62 | $226.62 | 399,157 |
| 10/14/2026 | $222.54 | $227.83 | $222.00 | $227.00 | $227.00 | 995,684 |
| 10/13/2026 | $225.99 | $228.91 | $222.21 | $223.21 | $223.21 | 592,238 |
| 10/12/2026 | $229.00 | $229.23 | $226.66 | $227.00 | $227.00 | 642,489 |
| 10/9/2026 | $225.08 | $233.96 | $223.96 | $229.23 | $229.23 | 815,700 |
| 10/8/2026 | $227.83 | $227.98 | $219.52 | $222.69 | $222.69 | 924,126 |
Analyst Price Targets
Based on 21 analysts covering ASND · as of Oct 22, 2026
Wall Street analysts forecast ASND stock price to rise 28.8% over the next 12 months.
Consensus
Strong Buy4.76 / 5.00
Avg. Target
US$307.62
+28.8% Upside
Previously US$306.65 on Oct 21, 2026
Current Price
US$238.90
Last close
Analyst Breakdown (21 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ASND's historical volatility
30-Day Vol
43.5%
Annualized
90-Day Vol
38.8%
Annualized
Trend (90d)
-26.5%
Annualized drift
90d Mean
US$217.35
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$231.49 | US$199.23 – US$268.97 |
| 60 trading days | US$224.31 | US$181.42 – US$277.34 |
| 90 trading days | US$217.35 | US$167.61 – US$281.86 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Ascendis Pharma AS
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Financials
- Revenue (TTM)
- $1.05B
- EBITDA
- $263.45M
- Profit Margin
- 70.85%
- ROE (TTM)
- 118.78%
- EPS (Diluted)
- 13.29
- Book Value
- 24.53
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ASND.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| POM | POMDOCTOR LIMITED American Depositary Shares | $3.01 | +352.77% |
| MIMI | Mint Incorporation Limited Class A Ordinary Shares | $1.09 | +118.80% |
| SHFS | SHF Holdings Inc | $0.15 | +71.52% |
| LESLQ | Leslie's, Inc. | $0.07 | +63.06% |
| XHLD | TEN Holdings, Inc. Common Stock | $0.91 | +52.46% |
| WHLR | Wheeler Real Estate Investment Trust, Inc. | $0.53 | +47.22% |
| SPHL | Springview Holdings Ltd Class A Ordinary Shares | $3.54 | +45.68% |
| SVRN | OceanPal Inc. | $36.76 | +41.49% |
ASND.US news timeline
1 article covering ASND.US, most recent first
Latest